Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Witt

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Pediatric Hematology and Oncology|July 18, 2022
Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia - a Population-Based Analysis of the Austrian Berlin-Frankfurt-Münster (BFM) Study GroupAnna Gidl, Anna Füreder, Martin Benesch, et al.
The Journal of Molecular Diagnostics : JMD|June 5, 2020
Assessment of Pre-Analytical Sample Handling Conditions for Comprehensive Liquid Biopsy AnalysisTeresa Gerber, Sabine Taschner-Mandl, Lisa Saloberger-Sindhöringer, et al.
Transfusion|October 1, 2010
Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient programNina Worel, Konrad Rosskopf, Peter Neumeister, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 10, 2014
First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantationRené Geyeregger, Christine Freimüller, Julia Stemberger, et al.
Therapeutic Advances in Hematology|June 1, 2022
Relapsed acute lymphoblastic leukaemia after allogeneic stem cell transplantation: a therapeutic dilemma challenging the armamentarium of immunotherapies currently available (case reports)Fiona Poyer, Anna Füreder, Wolfgang Holter, et al.
Cytotherapy|April 14, 2015
Selection of adenovirus-specific and Epstein-Barr virus-specific T cells with major histocompatibility class I streptamers under Good Manufacturing Practice (GMP)-compliant conditionsChristine Freimüller, Julia Stemberger, Michaela Artwohl, et al.
Journal of Clinical Apheresis|December 1, 2025
Real-World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis SystemAaron Haubner, Sebastian Mendoza, Hans Vrielink, et al.
Frontiers in Immunology|April 24, 2023
Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedureSabine Tischer-Zimmermann, Elisabeth Salzer, Tamires Bitencourt, et al.
Journal of Clinical Apheresis|June 11, 2019
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special IssueAnand Padmanabhan, Laura Connelly-Smith, Nicole Aqui, et al.
Journal of Clinical Apheresis|August 10, 2020
Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitisRasheed A Balogun, Amber P Sanchez, Reinhard Klingel, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Pediatric Hematology and Oncology|July 18, 2022
Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia - a Population-Based Analysis of the Austrian Berlin-Frankfurt-Münster (BFM) Study GroupAnna Gidl, Anna Füreder, Martin Benesch, et al.
The Journal of Molecular Diagnostics : JMD|June 5, 2020
Assessment of Pre-Analytical Sample Handling Conditions for Comprehensive Liquid Biopsy AnalysisTeresa Gerber, Sabine Taschner-Mandl, Lisa Saloberger-Sindhöringer, et al.
Transfusion|October 1, 2010
Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient programNina Worel, Konrad Rosskopf, Peter Neumeister, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 10, 2014
First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantationRené Geyeregger, Christine Freimüller, Julia Stemberger, et al.
Therapeutic Advances in Hematology|June 1, 2022
Relapsed acute lymphoblastic leukaemia after allogeneic stem cell transplantation: a therapeutic dilemma challenging the armamentarium of immunotherapies currently available (case reports)Fiona Poyer, Anna Füreder, Wolfgang Holter, et al.
Cytotherapy|April 14, 2015
Selection of adenovirus-specific and Epstein-Barr virus-specific T cells with major histocompatibility class I streptamers under Good Manufacturing Practice (GMP)-compliant conditionsChristine Freimüller, Julia Stemberger, Michaela Artwohl, et al.
Journal of Clinical Apheresis|December 1, 2025
Real-World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis SystemAaron Haubner, Sebastian Mendoza, Hans Vrielink, et al.
Frontiers in Immunology|April 24, 2023
Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedureSabine Tischer-Zimmermann, Elisabeth Salzer, Tamires Bitencourt, et al.
Journal of Clinical Apheresis|June 11, 2019
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special IssueAnand Padmanabhan, Laura Connelly-Smith, Nicole Aqui, et al.
Journal of Clinical Apheresis|August 10, 2020
Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitisRasheed A Balogun, Amber P Sanchez, Reinhard Klingel, et al.
Pageof 4